Endoprosthetic elbow replacement in patients with solitary metastasis resulting from renal cell carcinoma

Olaf Rolf1, Frank Gohlke

  • 1Department of Orthopaedics, University of Würzburg, König-Ludwig-Haus, Germany.

Insights

Solitary bone metastasis from renal cell carcinoma to the elbow is rare. Surgical resection with custom prostheses effectively reduced pain and restored function in four patients.

Area of Science:

  • Oncology
  • Orthopedic Surgery
  • Bone Metastasis

Background:

  • Renal cell carcinoma (RCC) is a common cancer.
  • Solitary bone metastasis occurs in 2.5% of RCC patients.
  • Elbow joint metastasis from RCC is exceptionally rare, with limited available data.

Purpose of the Study:

  • To evaluate the efficacy of radical resection and custom-made elbow prosthesis in patients with solitary elbow metastasis from RCC.
  • To assess pain reduction and functional outcomes post-surgery.
  • To review the literature and present our experience with this rare presentation.

Main Methods:

  • Case series of 4 patients with solitary elbow metastasis from RCC.
  • Surgical resection of the solitary metastatic lesion.
  • Reconstruction using custom-made elbow prostheses.
  • Assessment of pain and functional outcomes post-operatively.

Main Results:

  • All 4 patients experienced significant pain reduction after surgical reconstruction.
  • Good functional outcomes were reported by all patients post-surgery.
  • The treatment successfully controlled the tumor locally and restored elbow function.

Conclusions:

  • Radical resection of solitary osteolytic bone metastases from RCC to the elbow, followed by custom prosthesis reconstruction, is a viable treatment option.
  • This approach can effectively manage local tumor control, alleviate pain, and restore function.
  • A lengthy interval between primary RCC diagnosis and metastasis development may indicate a favorable prognosis, supporting aggressive treatment strategies.